160 related articles for article (PubMed ID: 34682866)
1. The Predominant Role of Arrestin3 in General GPCR Desensitization in Platelets.
Chaudhary PK; Kim S; Kim S
J Clin Med; 2021 Oct; 10(20):. PubMed ID: 34682866
[TBL] [Abstract][Full Text] [Related]
2. Role of GRK6 in the Regulation of Platelet Activation through Selective G Protein-Coupled Receptor (GPCR) Desensitization.
Chaudhary PK; Kim S; Jee Y; Lee SH; Park KM; Kim S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486261
[TBL] [Abstract][Full Text] [Related]
3. Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development.
Gurevich EV; Benovic JL; Gurevich VV
Neuroscience; 2002; 109(3):421-36. PubMed ID: 11823056
[TBL] [Abstract][Full Text] [Related]
4. RhoG protein regulates glycoprotein VI-Fc receptor γ-chain complex-mediated platelet activation and thrombus formation.
Kim S; Dangelmaier C; Bhavanasi D; Meng S; Wang H; Goldfinger LE; Kunapuli SP
J Biol Chem; 2013 Nov; 288(47):34230-34238. PubMed ID: 24106269
[TBL] [Abstract][Full Text] [Related]
5. Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors.
Zhang X; Wang F; Chen X; Li J; Xiang B; Zhang YQ; Li BM; Ma L
J Neurochem; 2005 Oct; 95(1):169-78. PubMed ID: 16181421
[TBL] [Abstract][Full Text] [Related]
6. Aspartic acid 564 in the third cytoplasmic loop of the luteinizing hormone/choriogonadotropin receptor is crucial for phosphorylation-independent interaction with arrestin2.
Mukherjee S; Gurevich VV; Preninger A; Hamm HE; Bader MF; Fazleabas AT; Birnbaumer L; Hunzicker-Dunn M
J Biol Chem; 2002 May; 277(20):17916-27. PubMed ID: 11867621
[TBL] [Abstract][Full Text] [Related]
7. Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets.
Li D; D'Angelo L; Chavez M; Woulfe DS
J Biol Chem; 2011 Feb; 286(5):3805-14. PubMed ID: 21106537
[TBL] [Abstract][Full Text] [Related]
8. GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets.
Chen X; Gupta S; Cooper M; DeHelian D; Zhao X; Naik MU; Wurtzel JGT; Stalker TJ; Goldfinger LE; Benovic J; Brass LF; McKenzie SE; Naik UP; Ma P
Blood Adv; 2020 Jan; 4(1):76-86. PubMed ID: 31899801
[TBL] [Abstract][Full Text] [Related]
9. Function of non-visual arrestins in signaling and endocytosis of the gastrin-releasing peptide receptor (GRP receptor).
Schumann M; Nakagawa T; Mantey SA; Howell B; Jensen RT
Biochem Pharmacol; 2008 Mar; 75(5):1170-85. PubMed ID: 18199425
[TBL] [Abstract][Full Text] [Related]
10. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
[TBL] [Abstract][Full Text] [Related]
11. Arrestins differentially regulate histamine- and oxytocin-evoked phospholipase C and mitogen-activated protein kinase signalling in myometrial cells.
Brighton PJ; Rana S; Challiss RJ; Konje JC; Willets JM
Br J Pharmacol; 2011 Apr; 162(7):1603-17. PubMed ID: 21175586
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptor kinase 2 and arrestin2 regulate arterial smooth muscle P2Y-purinoceptor signalling.
Morris GE; Nelson CP; Everitt D; Brighton PJ; Standen NB; Challiss RA; Willets JM
Cardiovasc Res; 2011 Jan; 89(1):193-203. PubMed ID: 20705669
[TBL] [Abstract][Full Text] [Related]
13. Preferential Interaction between the dopamine D2 receptor and Arrestin2 in neostriatal neurons.
Macey TA; Gurevich VV; Neve KA
Mol Pharmacol; 2004 Dec; 66(6):1635-42. PubMed ID: 15361545
[TBL] [Abstract][Full Text] [Related]
14. Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.
Woulfe DS; Lilliendahl JK; August S; Rauova L; Kowalska MA; Abrink M; Pejler G; White JG; Schick BP
Blood; 2008 Apr; 111(7):3458-67. PubMed ID: 18094327
[TBL] [Abstract][Full Text] [Related]
15. The protein tyrosine phosphatase PTPN7 is a negative regulator of ERK activation and thromboxane generation in platelets.
Inamdar VV; Reddy H; Dangelmaier C; Kostyak JC; Kunapuli SP
J Biol Chem; 2019 Aug; 294(33):12547-12554. PubMed ID: 31266805
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal regulation of β
Pearce A; Sanders L; Brighton PJ; Rana S; Konje JC; Willets JM
Cell Signal; 2017 Oct; 38():182-191. PubMed ID: 28733084
[TBL] [Abstract][Full Text] [Related]
17. Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses.
Shankar H; Murugappan S; Kim S; Jin J; Ding Z; Wickman K; Kunapuli SP
Blood; 2004 Sep; 104(5):1335-43. PubMed ID: 15142872
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
[TBL] [Abstract][Full Text] [Related]
19. Platelet desensitization induced by arachidonic acid is not due to cyclo-oxygenase inactivation and involves the endoperoxide receptor.
Carmo LG; Hatmi M; Rotilio D; Vargaftig BB
Br J Pharmacol; 1985 Aug; 85(4):849-59. PubMed ID: 2994786
[TBL] [Abstract][Full Text] [Related]
20. Distinct role of Pyk2 in mediating thromboxane generation downstream of both G12/13 and integrin αIIbβ3 in platelets.
Kim S; Cipolla L; Guidetti G; Okigaki M; Jin J; Torti M; Kunapuli SP
J Biol Chem; 2013 Jun; 288(25):18194-203. PubMed ID: 23640884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]